Serum and adipose tissue-derived extracellular vesicles as biomarker reservoirs in oesophageal adenocarcinoma

Oesophageal adenocarcinoma (OAC) is a highly aggressive malignancy with poor survival rates and rising global incidence. Despite research advances, no validated liquid biopsy biomarkers currently exist for OAC. Extracellular vesicles (EV), due to their role in intercellular communication and ability to carry molecular cargo, represent a promising source of diagnostic and prognostic biomarkers. This study explores the proteomic profiles of EV-enriched preparations derived from serum and adipose-conditioned media (ACM) of OAC patients and non-cancer controls. EV-enriched preparations were isolated using size exclusion chromatography and analysed via label-free liquid chromatography-mass spectrometry. Bioinformatic analysis included principal component analysis and pathway analysis. Kaplan-Meier survival analysis using public datasets evaluated the prognostic relevance of candidate EV proteins. Proteomic profiling identified 65 differentially expressed proteins in serum-derived EV-enriched preparations from OAC patients, enriched in angiogenesis and migration pathways. In adipose tissue-derived EV-enriched preparations, 680 proteins were differentially expressed in OAC patients, with 118 altered between people with obesity and people without obesity. Comparative analysis revealed six consistently upregulated proteins in both serum and adipose-derived EV-enriched preparations: MYL6, VCP, HSP90AB1, CLTC, CCT7, and TCP1. Of these, HSP90AB1, CCT7, and TCP1 were significantly associated with poorer overall survival. These results highlight the role of EV-enriched proteins in tumour progression and immune modulation. This study offers novel biomarker candidates for OAC diagnosis and prognosis, especially in the context of obesity. The identification of clinically relevant proteomic signatures supports the potential of EV-based liquid biopsies for non-invasive disease monitoring and personalised therapeutic strategies in OAC.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-06-25
DOI
https://doi.org/10.1038/s41598-026-59243-x
Primary Topic
Extracellular vesicles in disease
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Serum and adipose tissue-derived extracellular vesicles as biomarker reservoirs in oesophageal adenocarcinoma

Narayanasamy Ravi, Adriele Prina‐Mello, Aisling B. Heeran, Simone Marcone et al.
Scientific Reports
Extracellular vesicles in disease
article

Serum and adipose tissue-derived extracellular vesicles as biomarker reservoirs in oesophageal adenocarcinoma

Narayanasamy Ravi, Adriele Prina‐Mello, Aisling B. Heeran, Simone Marcone, Valéria Lima Passos, Aisling Ui Mhaonaigh, Gary Hannon, John Reynolds, Meghana Menon, Barry Moran, Jacintha O` Sullivan, Anshul Bhardwaj
article en

Abstract

Oesophageal adenocarcinoma (OAC) is a highly aggressive malignancy with poor survival rates and rising global incidence. Despite research advances, no validated liquid biopsy biomarkers currently exist for OAC. Extracellular vesicles (EV), due to their role in intercellular communication and ability to carry molecular cargo, represent a promising source of diagnostic and prognostic biomarkers. This study explores the proteomic profiles of EV-enriched preparations derived from serum and adipose-conditioned media (ACM) of OAC patients and non-cancer controls. EV-enriched preparations were isolated using size exclusion chromatography and analysed via label-free liquid chromatography-mass spectrometry. Bioinformatic analysis included principal component analysis and pathway analysis. Kaplan-Meier survival analysis using public datasets evaluated the prognostic relevance of candidate EV proteins. Proteomic profiling identified 65 differentially expressed proteins in serum-derived EV-enriched preparations from OAC patients, enriched in angiogenesis and migration pathways. In adipose tissue-derived EV-enriched preparations, 680 proteins were differentially expressed in OAC patients, with 118 altered between people with obesity and people without obesity. Comparative analysis revealed six consistently upregulated proteins in both serum and adipose-derived EV-enriched preparations: MYL6, VCP, HSP90AB1, CLTC, CCT7, and TCP1. Of these, HSP90AB1, CCT7, and TCP1 were significantly associated with poorer overall survival. These results highlight the role of EV-enriched proteins in tumour progression and immune modulation. This study offers novel biomarker candidates for OAC diagnosis and prognosis, especially in the context of obesity. The identification of clinically relevant proteomic signatures supports the potential of EV-based liquid biopsies for non-invasive disease monitoring and personalised therapeutic strategies in OAC.

Scientific Reports
University College Dublin (IE), Trinity College (CA), Trinity College Dublin (IE), St. James's Hospital (IE)
Irish Association for Cancer Research
No poverty
Openalex Percentile: Top 11%
Extracellular vesicles in disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.